Hirofumi Hamano

1.2k total citations
74 papers, 845 citations indexed

About

Hirofumi Hamano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Hirofumi Hamano has authored 74 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 12 papers in Hematology. Recurrent topics in Hirofumi Hamano's work include Lung Cancer Treatments and Mutations (7 papers), HER2/EGFR in Cancer Research (6 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). Hirofumi Hamano is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), HER2/EGFR in Cancer Research (6 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). Hirofumi Hamano collaborates with scholars based in Japan, United States and Taiwan. Hirofumi Hamano's co-authors include Yoshito Zamami, Yasumasa Ikeda, Yuya Horinouchi, Toshiaki Tamaki, Koichiro Tsuchiya, Licht Miyamoto, Keisuke Ishizawa, Yuki Izawa‐Ishizawa, Norio Haneji and Kumiko Yanagi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hirofumi Hamano

63 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirofumi Hamano Japan 16 225 162 156 143 137 74 845
Suzane L. Um United States 12 387 1.7× 116 0.7× 110 0.7× 193 1.3× 85 0.6× 25 1.1k
Philippe Zaoui France 20 401 1.8× 158 1.0× 138 0.9× 195 1.4× 94 0.7× 66 1.6k
Simona Mihai Romania 16 317 1.4× 170 1.0× 128 0.8× 49 0.3× 84 0.6× 27 1.2k
Huihui Li China 16 164 0.7× 90 0.6× 84 0.5× 162 1.1× 96 0.7× 38 683
Serena Valsami Greece 16 354 1.6× 153 0.9× 181 1.2× 195 1.4× 77 0.6× 59 1.1k
Heba F. Pasha Egypt 18 288 1.3× 135 0.8× 79 0.5× 46 0.3× 74 0.5× 42 919
Manuel Macı́a Spain 16 199 0.9× 111 0.7× 147 0.9× 83 0.6× 55 0.4× 35 1.2k
Daphne Stewart United States 10 321 1.4× 156 1.0× 73 0.5× 133 0.9× 36 0.3× 42 666
Haidong Yan China 20 657 2.9× 152 0.9× 175 1.1× 113 0.8× 90 0.7× 29 1.5k

Countries citing papers authored by Hirofumi Hamano

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Hamano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Hamano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Hamano more than expected).

Fields of papers citing papers by Hirofumi Hamano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Hamano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Hamano. The network helps show where Hirofumi Hamano may publish in the future.

Co-authorship network of co-authors of Hirofumi Hamano

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Hamano. A scholar is included among the top collaborators of Hirofumi Hamano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Hamano. Hirofumi Hamano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goda, Mitsuhiro, Takahiro Niimura, Kôji Miyata, et al.. (2025). Evaluation of Interstitial Lung Disease Complications Caused by Biologic Agents Using a Spontaneous Adverse Drug Reaction Reporting Database. Pharmacology Research & Perspectives. 13(2). e70063–e70063.
2.
Miyata, Kôji, Yuki Izawa‐Ishizawa, Masateru Kondo, et al.. (2024). Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments. Biomedicine & Pharmacotherapy. 179. 117418–117418. 1 indexed citations
3.
Hamano, Hirofumi, et al.. (2024). Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database. Frontiers in Pharmacology. 15. 1472008–1472008.
4.
Aizawa, Fuka, Hirofumi Hamano, Naoto Okada, et al.. (2024). Assessing the effects of interprofessional education by hospital pharmacists on pharmaceutical students using a self-evaluation scale. Journal of Pharmaceutical Health Care and Sciences. 10(1). 61–61.
5.
Tanaka, Yuta, Hisashi Ishida, Kaori Fujiwara, et al.. (2024). Letermovir at a Prophylactic Dose for Cytomegalovirus Infection in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study in Japan. Biological and Pharmaceutical Bulletin. 47(9). 1575–1582. 4 indexed citations
6.
Matsumoto, Jun, Naohiro Iwata, Takahiro Niimura, et al.. (2024). Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study. International Journal of Clinical Pharmacy. 46(3). 745–750. 4 indexed citations
7.
Nishimura, Yoshito, Ko Harada, Hiroki Ito, et al.. (2024). International trends in biliary tract cancer–related mortality, 2000–2022: An observational study of the World Health Organization Mortality Database. Hepatology. 82(3). 626–637. 3 indexed citations
8.
9.
Matsumoto, Jun, Naohiro Iwata, Aya Ozaki, et al.. (2024). A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases. International Journal of Clinical Pharmacy. 46(2). 536–541. 4 indexed citations
10.
Tanioka, Maki, Kenji Takada, Hirofumi Hamano, et al.. (2024). Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness. BioDrugs. 39(1). 131–142. 2 indexed citations
11.
Niimura, Takahiro, Mitsuhiro Goda, Kôji Miyata, et al.. (2023). Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination. SHILAP Revista de lepidopterología. 3. 1213771–1213771. 2 indexed citations
12.
Goda, Mitsuhiro, Yuki Izawa‐Ishizawa, Kenta Yagi, et al.. (2023). Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage. Clinical and Translational Science. 16(11). 2369–2381. 4 indexed citations
13.
Yagi, Kenta, Fuka Aizawa, Soichiro Ushio, et al.. (2023). Effects of vonoprazan and proton pump inhibitors on the efficacy of bevacizumab: a multicentre retrospective study. Clinical and Experimental Medicine. 23(6). 2799–2804. 4 indexed citations
14.
Hamano, Hirofumi, Takahiro Niimura, Aya Ozaki, et al.. (2023). Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics. International Journal of Cancer. 153(8). 1472–1476. 8 indexed citations
15.
Hamano, Hirofumi, Takahiro Niimura, Kenta Yagi, et al.. (2023). Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases. Toxicology and Applied Pharmacology. 475. 116632–116632. 4 indexed citations
16.
Chuma, Masayuki, Takahiro Niimura, Yutaka Kondo, et al.. (2022). Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis. Clinical Infectious Diseases. 75(8). 1416–1422. 21 indexed citations
17.
Goda, Mitsuhiro, Kôji Miyata, Fuka Aizawa, et al.. (2022). Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis. Clinical and Translational Science. 15(7). 1664–1675. 5 indexed citations
18.
Horinouchi, Yuya, Yasumasa Ikeda, Keijo Fukushima, et al.. (2018). Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis. Scientific Reports. 8(1). 10858–10858. 29 indexed citations
19.
Ikeda, Yasumasa, Yuya Horinouchi, Hirofumi Hamano, et al.. (2017). Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice. Scientific Reports. 7(1). 10621–10621. 26 indexed citations
20.
Abiko, Yoshihiro, et al.. (1989). Ultrastructure of basal cell adenoma in the parotid gland.. PubMed. 30(3). 145–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzane L. Um Breakdown of academic impact, for papers by Philippe Zaoui Breakdown of academic impact, for papers by Simona Mihai Breakdown of academic impact, for papers by Huihui Li Breakdown of academic impact, for papers by Serena Valsami Breakdown of academic impact, for papers by Heba F. Pasha Breakdown of academic impact, for papers by Manuel Macı́a Breakdown of academic impact, for papers by Daphne Stewart Breakdown of academic impact, for papers by Haidong Yan
Rankless by CCL
2026